TY  - GEN
AU  - Gabra,H
AU  - Cameron,D A
AU  - Lee,L E
AU  - Mackay,J
AU  - Leonard,R C
TI  - Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer
SN  - 0007-0920
PY  - 1997///0127
KW  - Adult
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Antimetabolites, Antineoplastic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Neoplasms
KW  - secondary
KW  - Brain Neoplasms
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intravenous
KW  - Injections, Intravenous
KW  - Liver Neoplasms
KW  - Lung Neoplasms
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1038/bjc.1996.668
ER  -